Events9th International Electronic Conference on Medicinal Chemistry
Published
with-doi10.3390/ECMC2023-15705 (registering DOI)
This submission belongs to the session S4. New Small molecules as drug candidates of the event 9th International Electronic Conference on Medicinal Chemistry
Published date
01 Nov, 2023
Academic Editor
author-avatarAlfredo Berzal-Herranz
Citation
Marina Vesović, Miloš Nikolić, Ratomir Jelić, Emina Mrkalić, Gordana Radić, Dušan Tomović, Zoran Ratković, Investigation of binding mode of isoamyl derivative of thiosalicylic acid and human serum albumin, in Proceedings of 9th International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2023, MDPI: Basel, Switzerland, doi: 10.3390/ECMC2023-15705
Share
Email
Facebook
Twitter
LinkedIn

Investigation of binding mode of isoamyl derivative of thiosalicylic acid and human serum albumin

image
image
Zoran Ratković 4
1. University of Kragujevac, Faculty of Medical Sciences, Department of Pharmacy, Svetozara Markovića 69, 34000 Kragujevac, Serbia, Serbia
2. University of Kragujevac, Faculty of Medical Sciences, Department of Pharmacy, Svetozara Markovića 69, Kragujevac 34000, Serbia, Serbia
3. University of Kragujevac, Institute for Information Technologies, Department of Science, Jovana Cvijića bb, Kragujevac 34000, Serbia, Serbia
4. University of Kragujevac, Faculty of Science, Department of Chemistry, Radoje Domanovića 12, 34000 Kragujevac, Serbia
5. University of Kragujevac, Faculty of Medical Sciences, Department of Pharmacy, Svetozara Markovića 69, Kragujevac 34000, Serbia, Serbia
Abstract

Thiosalicylic acid is known for its diverse pharmacological properties and its frequent use in various synthetic conversions. The unique structure of thiosalicylic acid permits the incorporation of diverse S-alkyl derivatives, resulting in favorable chemical characteristics for numerous applications. Therefore, affinity for one of the binding sites of human serum albumin (HSA) of isoamyl derivative of thiosalicylic acid (ligand, L), were examined. Binding mode of compound L was determined using fluorescence spectroscopy. Warfarin was used as a marker for Sudlow’s Site I (subdomain IIA), while ibuprofen was used as a marker for Sudlow’s Site II (subdomain IIIA). Obtained values of Ka suggested that investigated compound bind to HSA. Results of site marker competitive experiments showed that the tested L bind to HSA in domain IIA (Site I). The presented results will help to improve the research of the mechanism of the interaction between transport proteins and similar compounds.

Keywords
Human serum albumin
Thiosalicylic acid
Isoalkyl derivatives
Spectroscopic measurements
Manuscript
Investigation of the interaction between isopropyl derivative of thiosalicylic acid and human serum albumin
Obtaining and purifying esculin acetates through reactions catalyzed by Novozyme 435